The development of the mature insect trachea requires a complex series of cellular events, including tracheal cell specification, cell migration, tubule branching, and tubule fusion. Here we describe the identification of the Drosophila melanogaster dysfusion gene, which encodes a novel basic helix-loop-helix (bHLH)-PAS protein conserved between Caenorhabditis elegans, insects, and humans, and controls tracheal fusion events. The Dysfusion protein functions as a heterodimer with the Tango bHLH-PAS protein in vivo to form a putative DNA-binding complex. The dysfusion gene is expressed in a variety of embryonic cell types, including trachealfusion, leading-edge, foregut atrium cells, nervous system, hindgut, and anal pad cells. RNAi experiments indicate that dysfusion is required for dorsal branch, lateral trunk, and ganglionic branch fusion but not for fusion of the dorsal trunk. The escargot gene, which is also expressed in fusion cells and is required for tracheal fusion, precedes dysfusion expression. Analysis of escargot mutants indicates a complex pattern of dysfusion regulation, such that dysfusion expression is dependent on escargot in the dorsal and ganglionic branches but not the dorsal trunk. Early in tracheal development, the Trachealess bHLH-PAS protein is present at uniformly high levels in all tracheal cells, but since the levels of Dysfusion rise in wild-type fusion cells, the levels of Trachealess in fusion cells decline. The downregulation of Trachealess is dependent on dysfusion function. These results suggest the possibility that competitive interactions between basic helix-loop-helix-PAS proteins (Dysfusion, Trachealess, and possibly Similar) may be important for the proper development of the trachea.
The insect tracheal system consists of an intricately branched system of tubules that provide oxygen throughout the animal. The formation of the trachea consists of a series of developmental events, and its analysis provides an excellent model system for studying the morphogenesis of other branched structures, such as the vertebrate lung airways, circulatory system, kidney ducts, and excretory epithelia (9, 27, 38) . The trachea is derived from an array of segmentally repeated clusters of precursor cells. After the tracheal precursor cells divide and invaginate, they extend branches, and the branches from neighboring segments fuse to form the mature tracheal tree. The fusion process is mediated by a distinct fusion cell residing on each branch (41) . Branching and fusion are complex cellular processes and pose a number of developmental questions. How are fusion cells specified during tracheal development? What are the short-range and long-range factors that guide tracheal branches to their fusion partners? What is the nature of the adhesive and contact-guidance interactions that mediate fusion and allow the formation of adherens junctions that seal intercellular junctions? How is the cytoskeleton rearranged to allow the tracheal lumen to extend throughout the branch?
The tracheal primordia extend branches in six directions under the guidance of the branchless gene (44) . All of these branches except the visceral branch will fuse with tracheal branches derived from other primordia. The dorsal trunk is formed by fusion of anterior and posterior branches from adjacent segments, as is the lateral trunk, which is formed by fusion of lateral trunk anterior and posterior branches. The dorsal branches travel over the dorsal side of the embryo and fuse along the dorsal midline to their partner from the identical hemisegment. The ganglionic branches migrate ventrally and join at the ventral midline, although only the three anteriormost branches fuse. There is a single fusion cell for each branch, and the fusion cells are characterized by patterns of gene expression distinct from other tracheal cells (41) . The Escargot (Esg) zinc finger transcription factor is prominently expressed during tracheal development in fusion cells and no other tracheal cell (41, 42, 46) . esg mutants show fusion cell defects in the lateral trunk, dorsal branch, and ganglionic branch, but dorsal trunk fusion is relatively normal. Examination of esg mutants indicates that expression of several, but not all, fusion cell-specific genes and markers is absent in the dorsal branch and the ganglionic branch (42) , and there is an excess of branching and gene expression associated with branching. In addition, esg is required for DE-cadherin expression and the ability of fusion cells to form adhesive contacts and adherens junctions (46) . The loss of esg in lateral trunk is the most extreme, resulting in death of the fusion cells. Important issues regarding the tracheal function of esg deal with the identity of genes regulated by esg and why esg is required for tracheal fusion in some branches but not others.
Three proteins that function prominently in tracheal devel-opment are the Trachealess (Trh), Similar (Sima), and Tango (Tgo) basic helix-loop-helix (bHLH)-PAS proteins. Trh and Tgo form a heterodimer that controls transcription and initial formation of the tracheal primordia along with the Drifter (Dfr) POU-homeobox coactivator (4, 16, 32, 43, 50) . Sima and Tgo form a protein dimer that controls the transcriptional response to hypoxia (22, 29) . Since low cellular oxygen conditions induce additional tracheal branching (18) , Sima may autonomously or nonautonomously be required for terminal tracheal branching. Tgo is found in all embryonic cells. In the absence of a bHLH-PAS partner protein, Tgo is found in the cytoplasm, but in the presence of a partner protein, they dimerize, translocate into the nucleus, bind DNA, and activate transcription (49) . Since there may exist multiple bHLH-PAS partners of Tgo in the same cell, it has been proposed that the function and levels of bHLH-PAS proteins may be regulated by competitive interactions (13, 52) . In part for this reason, it is important to identify all Drosophila melanogaster bHLH-PAS proteins and determine where they are expressed.
In the present study, we describe a novel bHLH-PAS gene, dysfusion (dys), which is expressed in all tracheal fusion cells, as well as the epidermal leading edge cells and several other cell types. The dys gene is a member of a discrete subfamily of bHLH-PAS proteins conserved between nematodes, insects, and mammals. Tgo accumulates in nuclei of dys-expressing cells, suggesting that it is a partner of Dys in vivo. dys-RNAi experiments reveal tracheal fusion defects in the lateral trunk, dorsal branch, and ganglionic branch but not in the dorsal trunk. The esg gene is expressed in all fusion cells before dys, and esg expression is normal in dys RNAi-injected embryos. However, esg mutant embryos show an absence of dys expression in tracheal fusion cells in most branches, but not the dorsal trunk, further indicating branch-specific function of esg. The appearance of Dys in tracheal fusion cells coincides with a steep drop in Trh levels in fusion cells, and this reduction is dys dependent. This indicates that one function of dys in tracheal fusion cell development is to downregulate Trh protein levels. This provides the first in vivo evidence that bHLH-PAS proteins regulate levels of other bHLH-PAS proteins during development and possibly influence cell fate and morphogenetic decisions. Identification of dys gene and mRNA structure. The human hypoxia-inducible factor 1␣ (HIF-1␣) PAS-1 region was screened versus Drosophila genomic sequence data (1) by using tBLASTN (2) , and a novel bHLH-PAS-containing gene was identified at 96F on the third chromosome. Drosophila dys cDNA was cloned by using an reverse transcription-PCR (RT-PCR) strategy based on the genomic sequence. Initially, four pairs of primers predicted to be in dys coding sequences were utilized: (i) exons 2 and 3, S1 (ACGTGCGATCGACGATATGT) and A1 (CGCATTTATGAGATCGCGTC); (ii) exons 3 to 6, S2 (GATGCAAACAAA TCGACGAA) and A2 (ATCGTAAACGGAGTCACCGT); (iii) exons 5 to 8, S3 (GCTTCTTGATGATGCTCACA) and A3 (TTGCGCCTCCGTCAGATTAT); and (iv) exons 8 to 10, S4 (ATAATCTGACGGAGGCGCAA) and A4 (TCTG GCTTAAGTGCTGCGAA). Total RNA from an overnight collection of Drosophila embryos was extracted by using an RNeasy Mini Kit (Qiagen). Poly(A) ϩ mRNA was extracted from total RNA by using Oligotex (Qiagen). First-strand cDNA was synthesized by using SuperScript reverse transcriptase (Gibco-BRL) and used as a template for PCRs. PCR amplification of primer pairs 1 to 4 resulted in the generation of dys cDNA fragments of 515, 388, 665, and 1,141 bp. The amplified fragments were cloned into pCR2.1-TOPO (Invitrogen) and sequenced at the UNC Automated Sequencing Facility.
MATERIALS AND METHODS

Drosophila
5-RACE. The 5Ј-most dys sequences were obtained by performing 5Ј RACE (rapid amplification of cDNA ends) with a SMART RACE cDNA amplification kit (BD Biosciences). First-strand cDNA was synthesized from poly(A) ϩ RNA at 42°C for 1 h with PowerScript reverse transcriptase by using dys internal primer A3 (TTGCGCCTCCGTCAGATTAT). The SMART II A oligonucleotide (AA GCAGTGGTATCAACGCAGAGTACGCGGG) was included. This oligonucleotide anneals to the C-rich cDNA 3Ј tail and serves as a primer for secondstrand DNA synthesis. Primer S5 (TCGTCTGCGGCTGCTGCTGTTGC), derived from the dys sequence, was used to perform PCRs for 5Ј RACE, along with a universal primer (CTAATACGACTCACTATAGGGCAAGCAGTGGT ATCAACGCAGAGT) that can anneal to the SMART II A oligonucleotide sequence. The amplified fragments were cloned and sequenced.
3 RACE. The 3Ј-most dys sequences were obtained by performing 3Ј RACE with a SMART RACE cDNA amplification kit. First-strand cDNA was synthesized from poly(A) ϩ RNA at 42°C for 1 h with reverse transcriptase by using the oligo(dT)-based 3Ј-RACE CDS primer A [AAGCAGTGGTATCAACGCAGA GTAC(T) 30 N Ϫ1 N, where N is A, C, G, or T and N Ϫ1 is A, C, or G]. The 3Ј RACE forward primer (GATGTCAGATCCTTTGGTACCGGTCACGTA) was derived from the dys sequence and used in PCRs along with the universal primer that can anneal to primer A. All amplified fragments were cloned and sequenced.
Sequence comparisons and phylogenetic analysis. The Dys bHLH sequence was aligned to bHLH sequences from representatives of all subfamilies of bHLH-PAS proteins by using CLUSTALX (48) . The alignment was then used to create a phylogenetic tree by using the neighbor-joining method (40) and PAUP*4.0 software (45) . Clades were assessed by bootstrap analysis of 1,000 repetitions. The tree was visualized with TreeView (33) . The Dys sequence from Anopheles gambiae was determined by searching the Anopheles genome sequence (15) for Dys-related sequences. Significant homology was observed for all exons except exons 1, 2, and 4. The Caenorhabditis elegans cDNA clone sequence of C15C8.2 was provided by JoAnne Powell-Coffman (Iowa State University), and the human NXF (H-NXF) sequence was provided by Cam Patterson (University of North Carolina at Chapel Hill).
Dys antibody production. Polyclonal antibodies against Dys were generated by using a Dys fusion protein containing an N-terminal His 6 tag. A dys cDNA fragment corresponding to amino acids (aa) 584 to 803 was cloned into the XhoI site of pET-15b (Novagen). After transformation into Escherichia coli BL21(DE3), cells were grown and His-Dys fusion protein synthesis induced by the addition of IPTG (isopropyl-␤-D-thiogalactopyranoside). Inclusion bodies were prepared, solubilized in 10% sodium dodecyl sulfate (SDS), dialyzed in 0.05% SDS-1 mM phenylmethylsulfonyl fluoride-1ϫ phosphate-buffered saline, and purified by using Talon metal affinity resins (Clontech). The eluted His-Dys protein was then dialyzed in 0.01% SDS-1ϫ phosphate-buffered saline. Two rats and two rabbits were immunized by subcutaneous injection of protein (Pocono Rabbit Farm & Laboratory).
Drosophila immunostaining. Whole-mount embryos were immunostained as described previously (34) . The following primary antibodies and dilutions were used for immunostaining: rat anti-Dys (1:200), rabbit anti-Dys at 1:800, mouse monoclonal antibody (MAb) 2A12 at 1:10 (24), MAb anti-Tgo at 1:1 (49), MAb anti-␤-galactosidase (anti-␤-Gal) (Promega) at 1:1,000, rabbit anti-␤-Gal (Cappell) at 1:2,000, and rat anti-Trh at 1:200 (49) . The following secondary antibodies were used: fluorescein isothiocyanate-labeled anti-mouse and anti-rat immunoglobulin G (IgG; Molecular Probes), Texas red-labeled anti-rabbit and antimouse IgG (Jackson Laboratories), Alexafluor 594-labeled anti-mouse IgM, Cy5-labeled anti-mouse IgG (Molecular Probes), alkaline phosphatase (AP)-labeled anti-rat IgG and IgM, and biotin-SP-labeled anti-mouse IgG (Jackson Laboratories) used with streptavidin-horseradish peroxidase. All secondary antibodies were used at 1:200 except for Alexafluor 594-labeled anti-mouse IgM, which was used at 1:1,000. Nonfluorescence staining was developed by using either AP color development buffer (Bio-Rad) or diaminobenzidine with horseradish peroxidase. Photomicrographs were taken with either Zeiss LSM-510 confocal or Axiophot microscopes.
Drosophila in situ hybridization. Drosophila whole-mount embryos were hybridized in situ to a Drosophila dys antisense RNA probe. The probe was 1.1 kb and was generated by PCR amplification of a dys cDNA clone. The primers A4 and S4 were used, and the region amplified included exons 8 to 10. The PCR product was cloned into PCRII-TOPO, and a digoxigenin (DIG)-labeled RNA
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probe was synthesized by using SP6 RNA polymerase (Promega) at 37°C for 2 h. The probe was added to the hybridization buffer (50% deionized formamide; 5ϫ SSC [1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate]; 100 g of sonicated, denatured salmon sperm DNA/ml; 100 g of E. coli tRNA/ml; 50 g of heparin/ ml; 0.1% Tween 20; pH 4.5). Hybridization was carried out for 16 h at 70°C. After a washing step, the presence of dys mRNA was detected by incubating embryos with AP-conjugated anti-DIG antibody (1:1,000) and reaction with nitroblue tetrazolium plus X-phosphate. Embryos were mounted in 70% glycerol and examined under bright-field optics. RNAi. Double-stranded RNA (dsRNA) for RNA interference (RNAi) experiments was prepared for dys and for green fluorescent protein (GFP) by using modifications of existing protocols (20, 28) . The GFP-dsRNA acted as a negative control. The templates used for synthesis of dsRNA were the products of twostep PCR. The first step amplified a fragment of cDNA that contains a partial T7 RNA polymerase promoter site. The second PCR step amplified the fragment and completed the addition of a T7 RNA polymerase site adjacent to both ends of the cDNA sequence. The first PCR used to amplify dys cDNA utilized the following primer pair: 5Ј-CGACTCACTATAGGGCGACTCCACGCAACAA CCTG-3Ј and 5Ј-CGACTCACTATAGGGTCTGGCTTAAGTGCTGCGAA-3Ј (the T7 sequences are underlined). This fragment includes 1,027 bp (residues 1399 to 2426; exons 6 to 10) of the dys sequence. The GFP-dsRNA template was generated by amplifying a 729-bp fragment of pNEGFPX.1 that contains the GFP gene. The primer pair used was 5Ј-CGACTCACTATAGGGATGGTGA GCAAGGGCGAGGAG-3Ј and 5Ј-CGACTCACTATAGGGGTACAGCTCG TCCATGCCGAG-3Ј. The second step of the PCR used the T7 promoter sequence (ATAGAATTCTCTAGAAGCTTAATACGACTCACTATAGGG) as a primer. This resulted in an amplified fragment with T7 RNA polymerase sites at both ends, allowing the simultaneous synthesis of sense and antisense RNA. DNA templates were purified by using QIAquick PCR purification kit (Qiagen). dsRNAs were synthesized by using T7 RNA polymerase and DNA templates were removed with RNase-free DNase. After phenol-chloroform extraction and ethanol precipitation, the dsRNAs were dissolved in Tris-EDTA (TE) at a final concentration of 5 M. Analysis of dsRNAs by agarose gel electrophoresis indicated that bands of the expected sizes were present.
Injection needles were baked to remove RNase for injection. Embryos from w 1118 or esg 05730 flies were collected over a 60-min period at 25°C and attached to a coverslip with double-stick tape. They were covered in no. 700 halocarbon oil and dsRNA solution injected into the ventral and/or posterior side of the embryo along ca. 30 to 50% of the egg length by using a Picospritzer III Picopump. The injected embryos were incubated at 18°C for 26 h and at stages 15 and 16 were collected, dechorionated, fixed, devitellinized, and immunostained. Other embryos were allowed to hatch into first-instar larvae and then transferred to vials. After further incubation at 25°C, the tracheal phenotypes of second-instar larvae were examined by bright-field microscopy.
dys viability assays. dys-dsRNA and GFP-dsRNA-injected larvae were transferred to vials with fly food at a density of 40 larvae/vial and then incubated at 25°C. The number of pupae and emerging adults were counted for each vial.
RESULTS
Identification and sequence of the Drosophila dys gene.
Bioinformatic searches for additional Drosophila bHLH-PAS genes utilized bHLH and PAS sequences screened against the genomic sequence generated by the Celera/Berkeley Drosophila Genome Project (BDGP) (1) . When a human HIF-1␣ PAS-1 region was screened against Drosophila genomic DNA by using the tBLASTN algorithm (3), a novel bHLH-PAS gene was identified in the BAC clones BACR13F13 and BACR08G22, which map to a cytological position, 96F-97A, on chromosome 3. Later, the gene was also identified by the BDGP-Celera Consortium by using the Genie algorithm (37) and in global searches for bHLH genes (23, 35) . Genie initially predicted four distinct genes in the region, three of which contain multiple predicted exons: CG14554 (one exon), CG12561 (three exons), CG14553 (three exons), and CG14552 (four exons). Using RT-PCR and DNA sequence analysis, we showed that these four predicted genes all constitute a single gene, dys, now referred to as CG32474 (Fig. 1A) . dys maps to 96F9-10 according to FlyBase (11) .
Preliminary experiments indicated that dys is a rare embryonic mRNA, an observation consistent with its absence from the BDGP embryonic expressed sequence tag (EST) collection of 8,809 distinct mRNAs. RNA was isolated from Drosophila embryos, and RT-PCR was carried out with primers designed from genomic sequences. The 5Ј and 3Ј ends of the mRNA were identified by RACE. These experiments provide the sequence of the dys mRNA. The genomic sequence comprises 10 exons and spans 21,697 bp (Fig. 1A) . The 5Ј-untranslated region (UTR) determined by RACE is predicted to be 521 nucleotides (nt), and the 3Ј-UTR is 500 nt. Of particular interest, the 3Ј-UTR of dys, which resides in exon 10, overlaps by 475 bp the sequence of EST LP05454 (39) , which is transcribed in the other direction (Fig. 1A) .
The coding sequence of dys (Fig. 1B) shows a clear relationship to other bHLH-PAS proteins (8, 47) . It has a bHLH domain near the N terminus, followed by PAS-1 and PAS-2 domains. The C-terminal regions of bHLH-PAS proteins generally contain transcriptional activation domains (see, for example, reference 12), although the protein sequences are poorly conserved. Consistent with that observation, the Cterminal region of Dys shows little homology with other proteins but contains histidine-rich and proline-rich regions similar to the C terminus of other bHLH-PAS proteins (8) . The region N terminal to the bHLH domain encoded by exons 1 and 2 is 152 aa, which is uncharacteristically long for bHLH-PAS proteins. This region contains a large number of glutamine residues, suggesting that at it may act as an N-terminal transcriptional activation domain. There is also an unusually long spacer region in the PAS-1 domain that contains a large number of serines and repeats of Gly-Gly-Ala. The length of the predicted protein is 918 aa with a predicted molecular mass of 102 kDa.
Dys-related proteins constitute a discrete subset of evolutionarily conserved bHLH-PAS proteins. Sequence comparisons of all existing bHLH-PAS proteins to Dys reveal that it is a member of a discrete subfamily of bHLH-PAS proteins ( Fig.  1C and 2 ). The complete sequences of representative bHLH-PAS proteins were compared by CLUSTALX and displayed by a phylogenetic tree generated by the neighbor-joining method algorithm (40) . C. elegans C15C8.2 (7) (J. Powell-Coffman, unpublished data), Drosophila Dys (D-Dys), A. gambiae Dys (An-Dys) (15) , and H-NXF (6, 30) (C. Patterson, unpublished data) cluster as a discrete branch of the phylogenetic tree consisting of representative bHLH-PAS proteins (Fig. 2) . This result indicates that a dys ancestral gene existed before the divergence of nematodes, insects, and vertebrates. Quantitatively, the bHLH region of D-Dys shows the following percent identities to the other Dys subfamily proteins: An-Dys (96%), H-NXF (58%), and C15C8.2 (57%) (Fig. 1C) . The percent identity was only 30% within the bHLH region to the next closest bHLH-PAS protein, Drosophila Spineless (Ss). Similar relationships were observed by comparing PAS-1 domains and PAS-2 domains, although the percent identity was less than for the bHLH region, as generally observed with bHLH-PAS protein comparisons. The PAS-1 domain of Dys is characterized by a long insertion containing a number of Gly-Gly-Ala repeats. This insertion is absent in C15C8.2 and H-NXF, but VOL. 23, 2003 DROSOPHILA dysfusion GENE CONTROLS TRACHEAL FUSION 5627
An-Dys has an even larger insertion with a different sequence content consisting of stretches of His, Ser, and Gly. In contrast, the PAS-2 domain is similar in length and colinear between the subfamily members. Sequences N-terminal to the bHLH domain, the spacer between bHLH and PAS-1 domains, and the regions C-terminal to the PAS-2 domain are poorly conserved among subfamily members, whereas the spacer between PAS-1 and PAS-2 shows significant sequence identity.
dys is expressed in diverse embryonic cell types. Antisera were prepared against bacterially synthesized Dys protein derived from the unconserved C-terminal region of the protein, and whole-mount embryos were immunostained. Dys protein was found in a number of embryonic cell types (Fig. 3A to C) , and these sites of expression were identical to those observed for dys RNA, as determined by dys in situ hybridization ( Fig.  3D and E) (32) . The specificity of Dys antisera was further Representatives of all families of bHLH-PAS proteins were compared by using the bHLH domain protein sequences and aligned by using CLUSTALX. The alignment is represented by a phylogram generated by using the neighbor-joining method. The tree demonstrates that DroDys, AnoDys, CeC15C8.2, and H-NXF (HumNXF) represent a distinct, evolutionarily conserved subfamily of bHLH-PAS proteins (bracket). The scale represents the fraction of nonidentical amino acids residues along each branch. Numbers along each branch are the bootstrap confidence limits with 1,000 repetitions. The identities of the other proteins can be found in Taylor and Zhulin (47) . The species designation precedes each protein acronym (Ano, A. gambiae; Ce, C. elegans; Dro, Drosophila; Mur, murine; Hum, human).
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DROSOPHILA dysfusion GENE CONTROLS TRACHEAL FUSION 5629 (vi) the anal pad (Fig. 3A to C) . The frontal ganglion consists of cells of the stomagastric nervous system located between the brain and roof of the pharynx (14) . Expression remains in all of these cell types through the remainder of embryonic development. All Dys-positive cells showed nuclear localization (Fig. 4  to 6 ). The leading-edge and tracheal cells are conclusively identified in the present study, and more-detailed analyses of the other Dys-positive cells will be provided elsewhere. dys is expressed in the leading edge. During the process of dorsal closure, the dorsalmost rows of cells on each side are referred to as the leading edge. These cells (i) are required for the process of dorsal closure, (ii) respond to cellular signals regulating closure, and (iii) form the dorsal zipper after closure (21) . These cells are characterized by changes in cell shape during the closure process (17), and they interdigitate and adhere to each other after meeting at the dorsal midline. dys was examined for expression in the leading-edge cells by examining for colocalization with Puckered (Puc). The puc gene is expressed in the leading edge, and puc A251.1F3 , an enhancer trap line with a P[lacZ] insertion in the puc gene expresses lacZ in the leading edge cells (25) . Double staining embryos with anti-Dys and anti-␤-Gal revealed colocalization of the two proteins (Fig. 4) . dys is expressed in tracheal fusion cells. Dys protein was observed in four distinct longitudinal, segmentally repeated sets of cells along the ectoderm (Fig. 3A to C) . The locations of these cells resembles the pattern of genes expressed exclusively in tracheal fusion cells (41) . Embryos were double stained with MAb 2A12, which stains the tracheal lumen, and anti-Dys to determine the relationship between Dys-positive cells and the trachea (Fig. 5) . Before fusion, each branch contained a single Dys-positive cell, whereas after fusion there were two Dys-positive cells at the fusion site of each branch. This was observed at all sites of tracheal fusion, including the dorsal trunk, lateral trunk, dorsal branch, and ganglionic branch, but in no other tracheal cells. Only the three most anterior (G0, G1, and G2) of the 10 ganglionic branches fuse at the ventral midline. These three branches possess Dys-positive cells, but the others do not. Confirmation that the Dyspositive cells are tracheal fusion cells was shown by double staining an escargot-lacZ (esg-lacZ) enhancer trap line with anti-␤-Gal and anti-Dys (Fig. 6) (Fig. 6) . However, dys expression in the lateral trunk still precedes its fusion. The dorsal branches and ganglionic branches fuse later (stages 16 to 17) than the lateral trunk and dorsal trunk (data not shown), and dys expression also appears later (stage 14) than in the dorsal trunk and lateral trunk. Thus, Dys protein appears before fusion of each branch, and its appearance in each branch type correlates with the timing of branch fusion.
Dys colocalizes with nuclear Tgo in vivo.
Since Tgo is nuclear only in the presence of a partner bHLH-PAS protein, if Dys and Tgo dimerize in vivo, Tgo should be found in nuclei of Dys-positive cells. Embryos were double stained for Dys and Tgo (Fig. 7) . Most relevant are the leading-edge cells, since no other bHLH-PAS proteins are known to be expressed in these cells. Strong Tgo nuclear localization was observed that overlaps exactly with Dys ( Fig. 7A and B) . Tracheal fusion cells were also examined for nuclear Tgo levels. Examination of fusion cells of all four types of branches indicated high levels of nuclear Tgo accumulation colocalizing with Dys nuclear localization ( Fig. 7C to H) . These results are consistent with Tgo being a partner for Dys in vivo, although the presence of Trh in tracheal fusion cells could also contribute to Tgo nuclear localization (but see below). Of particular note is the finding that, qualitatively, the levels of nuclear Tgo appear constant in fusion cells throughout development, both before and after the appearance of Dys.
Injection of dys-dsRNA results in tracheal fusion defects. The relationship between dys expression and tracheal fusion branches suggests a role of dys in tracheal fusion events. Mutants of dys are not available, so dys-RNAi was utilized to test function. dys-dsRNA was injected into embryos, and tracheal development was assessed. Negative controls included embryos injected with TE and GFP-dsRNA. Staining of dysdsRNA-injected embryos with anti-Dys indicated that Dys protein was undetectable (Fig. 8A and B and 9 ). An indication that dys is required for normal development is demonstrated by the increased lethality of dys-dsRNA-injected embryos compared to those injected with negative controls. 98% of the embryos (n ϭ 200) injected with dys-dsRNA died before adulthood compared to 48% injected with GFP-dsRNA (n ϭ 200). Both samples had similar levels of embryos hatching into larvae: 66% of dys-dsRNA injected embryos hatched and 62% injected with GFP-dsRNA hatched. Thus, dys is probably not required for embryonic viability. The dys ds-RNA-injected embryos that survived embryonic development died as secondand third-instar larvae.
Since loss of dys function is lethal and dys is prominently expressed in tracheal fusion cells, we examined dys-dsRNAinjected embryos for defects in tracheal fusion. Injected embryos were analyzed by (i) immunostaining with MAb 2A12, which stains the tracheal lumen and outlines tracheal branches, 
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and (ii) examination of larval tracheae by using bright-field optics. The results showed a complete absence of lateral trunk, dorsal branch, and ganglionic branch fusion in embryos injected with dys-dsRNA. Embryos injected with TE or GFPdsRNA showed normal tracheal fusion. In wild-type embryos, lateral trunk fusion occurs at stage 15 when the anterior lateral trunk buds and posterior lateral trunk buds from adjacent segments fuse ( Fig. 8A and C) (24) . Embryos at stage 15 or older and larvae from dys-dsRNA-injected embryos do not have fused lateral trunks ( Fig. 8B and D) . The frequency of dys-dsRNA-injected embryos with lateral trunk defects was 92% (n ϭ 25). Each embryo with lateral trunk defects showed a lack of lateral trunk tracheal fusion in all segments, indicating that expressivity was at 100%. In contrast, every embryo injected with TE or GFP-dsRNA (n ϭ 10 each) showed fused lateral trunks in all segments. The specificity of the dys-RNAi treatment was validated for several reasons: (i) the overall embryonic morphology was normal, (ii) many embryos with tracheal fusion defects were healthy enough to hatch and survive until the second-and third-instar stages, (iii) tracheal branching and morphology were generally normal (the only gross defects were in fusion), and (iv) control embryos had normal tracheal fusion, whereas dys-RNAi embryos showed a high degree of fusion defects. Examination of the larval dorsal and ganglionic branches in dys-dsRNA-injected individuals showed a complete absence of fusion ( Fig. 8E to H) . No segments were observed with fused dorsal branch or ganglionic branches. Branching and migration of the dorsal branch and the ganglionic branch were essentially normal; only fusion defects were observed. Dorsal trunk fusion appeared normal (Fig. 8I and J) , even though dorsal trunk fusion cells express dys, and Dys protein was absent in dysdsRNA-injected embryos. The lack of dorsal branch, lateral trunk, and ganglionic branch fusion and the presence of dorsal trunk fusion in dys-dsRNA-injected embryos roughly mimics mutations in esg, which also affect dorsal branch, lateral trunk, and ganglionic branch fusion but not dorsal trunk fusion (42, 46) . It was not possible to confirm the dys-RNAi results genetically, since analysis of the Df(3R)Espl3 dys deletion strain was uninformative. Staining of Df(3R)Espl3 with anti-Trh and MAb 2A12 showed only the rudiments of antibody-positive staining, and these mutant embryos lack identifiable tracheae, presumably due to the deletion of genes other than dys (data not shown). Thus, fusion events could not be assayed.
Dys downregulates levels of Trh. trh is expressed in all tracheal cells at the beginning of tracheal development and acts as a master regulator of tracheal development. Trh proteins levels remain high during tracheal development in most tracheal cells (Fig. 6) (49) . Since Tgo is the likely dimerization partner for both Dys and Trh, and these proteins could, in principle, compete for Tgo in the same cells, we examined whether Trh levels remained constant in tracheal fusion cells in the presence of high levels of Dys. Heterozygous esg 05730 embryos expressing esg-lacZ to mark fusion cells were stained for Dys, ␤-Gal, and Trh (Fig. 6 ). Before dys is expressed, Trh is at high levels in fusion cells at equivalent levels to adjacent tracheal cells. As Dys protein accumulates in the fusion cells, Trh levels decline and remain low through the end of tracheal development. This occurs in fusion cells in the dorsal trunk (Fig. 6 ), lateral trunk (Fig. 6 ), dorsal branch (not shown), and ganglionic branch (not shown). Examination of Dys-positive tracheal fusion cells (n ϭ 82) indicated that 93% showed a marked reduction in Trh levels compared to adjacent tracheal cells.
The requirement of dys in regulating Trh levels was examined by staining esg 05730 esg-lacZ embryos injected with dysdsRNA for Trh in fusion cells (Fig. 9) . Only heterozygous embryos were examined. Tracheal fusion cells were identified by staining for ␤-Gal. Levels of ␤-Gal in fusion cells were comparable to control-injected embryos, indicating that esg transcription is not substantially affected by the depletion of Dys. Trh levels in Dys-depleted fusion cells were at high levels comparable to the levels observed in adjacent tracheal cells. Quantitatively, 96% of fusion cells examined in dys-dsRNAinjected embryos showed high levels of Trh (n ϭ 23 cells). This indicates that the reduction in Trh levels in fusion cells is dependent on dys function.
The trh, tgo, and dfr genes encode a transcription factor complex that is required for the development of tracheal cells from dorsal ectoderm and, directly or indirectly, the expression of most genes expressed in the trachea (4, 16, 50, 53) . Appearance of Trh protein precedes Dys by several hours (50) . The expression of dys was examined in a trh mutant background and found to be absent (data not shown). Thus, trh is required for dys expression, and Dys, in turn, modulates Trh levels. 
DROSOPHILA dysfusion GENE CONTROLS TRACHEAL FUSION 5633 mutants revealed that expression of fusion cell genes was affected in some branches (dorsal branch and ganglionic branch) but not others (dorsal trunk) (42, 46) . In the dorsal branch and the ganglionic branch, several fusion cell genes required esg function, but others did not. Expression of dys follows esg expression in all tracheal branches, raising the possibility that its expression requires esg function. Multiple esg mutants were analyzed, including the deletion strain esg G66 (Fig. 10) . Analysis of esg G66 mutant embryos showed a complete absence of dorsal branch and ganglionic branch dys expression in esg mutant fusion cells. The lateral trunk also had no Dys-positive cells but had some esg-lacZ-positive cells, a result consistent with an earlier report that lateral trunk fusion cells die in esg mutant embryos (42) . Thus, it is difficult to assess whether esg controls dys expression in the lateral trunk. In contrast, all dorsal trunk fusion cells were Dys positive. The P-element mutant, esg 05730 , showed a less severe phenotype. The dorsal branch fusion cells were all Dys negative, and dorsal trunk fusion cells were all Dys positive, as with the esg G66 mutant embryos. However, there were occasionally esg-lacZ-positive cells present in the defective, unfused lateral trunk branches; some were Dys positive, and some were Dys negative. This was also observed in esg G66 , but only rarely. The ganglionic fusion cells of esg 05730 were also occasionally Dys positive. In summary, dys fusion cell expression requires esg in fusion cells of the dorsal branch and ganglionic branch, and possibly the lateral trunk, but not in the dorsal trunk.
DISCUSSION
Drosophila Dys is a member of a distinct bHLH-PAS subfamily. Drosophila Dys belongs to a novel conserved subfamily of bHLH-PAS proteins that includes C. elegans C15C8.2 and H-NXF. Dys also likely belongs to an extended family of Drosophila bHLH-PAS proteins, including Sim, Sima, Ss, and Trh, that dimerize with Tgo. The protein structure of Dys is conventional for bHLH-PAS proteins. The bHLH domain is near the N terminus of the protein and is followed by the PAS-1 and PAS-2 domains. One unusual feature compared to other bHLH-PAS proteins is the relatively long (152 aa) region Nterminal to the bHLH domain. This region has a large number of glutamine residues and may act as a transcriptional activation domain. The C-terminal residues after the PAS-2 domain are unconserved with C15C8.2, H-NXF, or any other protein but have histidine-rich, proline-rich, and glutamine-rich regions. These residues may also be transcriptional activation domains. The structure of the Dys protein suggests a DNA- binding transcriptional activator, but this needs to be tested biochemically. dys is expressed in a variety of embryonic cell types. Drosophila dys is expressed in a variety of embryonic cell types, including tracheal fusion, leading edge, foregut atrium, brain or stomagastric nervous system, hindgut, and anal pad cells. Initial expression was observed during mid embryogenesis at stage 12. The function of dys in these cell types is unknown, with the exception of the tracheal fusion cells, in which we showed that dys plays a developmental role. The dys-RNAi results showed that dys is an essential gene. However, dysdsRNA-injected embryos did not die as embryos, but as second-and third-instar larvae. Thus, the role of dys, as assayed by RNAi, in the various embryonic cell types is not dramatic enough to cause embryonic lethality. Mutations in esg show fusion defects in the same tracheal branches as dys and are also lethal to larvae. The tracheal fusion defects and resulting putative respiratory deficiencies may be the cause of the larval lethality, since other observations have shown that animals with defective tracheae survive until late larval periods (24) . However, both genes are expressed elsewhere, and defects in the other cell types may contribute to lethality.
dys is required for tracheal fusion. dys is expressed in tracheal fusion cells, and no other tracheal cells. This was shown by coexpression of dys with esg, a gene that is expressed in fusion cells and regulates tracheal fusion. dys-RNAi experiments were carried out to examine whether dys is involved in tracheal fusion. The results demonstrated that dys was required for fusion of the dorsal branch, lateral trunk, and ganglionic branch but not of the dorsal trunk. This phenotype was similar to the esg mutant phenotype that also affected the dorsal branch, lateral trunk, and ganglionic branch but not the dorsal trunk. Although branches differ in the details of the fusion process, tracheal fusion generally requires migration, recognition, and adhesion of fusion cells. dys-RNAi embryos showed relatively normal tracheal branches and migration. The occurrence of a single esg-lacZ cell in each dys-RNAi branch indicated that esg-positive tracheal fusion cells were present, and thus survival and gross cell fate is not controlled by dys. It is possible that dys controls aspects of fusion cell recognition, cell adhesion, or inhibition of nonfusion tracheal functions, such as branching.
Since dys, as well as esg, is expressed in dorsal trunk fusion cells, why is dorsal trunk fusion apparently unaffected in dysRNAi-injected embryos? It is not likely due to incomplete expressivity of the dys-RNAi, since we were not able to detect Dys protein in dys-RNAi-injected embryos, including dorsal trunk fusion cells, and ϳ100% of lateral trunk, dorsal branch, and ganglionic branch branches in dys-dsRNA-injected embryos failed to fuse. As discussed previously (46) , there are a number of differences between the dorsal trunk and the other branches that could contribute to differences in fusion behav- ior. The larger diameter dorsal trunk has multiple cells comprising its circumference, unlike most of the other branches, which are thinner and have a single cell comprising the circumference. Dorsal trunk branches are in close proximity to their fusion partner and lack the filopodial extensions that help guide the other branches to their targets. The dorsal trunk also utilizes a mesodermal guidepost cell that mediates fusion (51) . Similar guidepost cells have not been described for the other branches. Finally, breathless RNA levels begin to decline by stage 12 in the dorsal trunk due to spalt repression (31) , which may eliminate the potential need to reduce breathless levels by decreasing Trh levels. These and other possible differences suggest why dys and esg may have different functions in different branches.
The esg gene is required in dorsal branch and ganglionic branch tracheal fusion cells for expression of several genes, including shotgun (DE-cadherin) and three late-expressing fusion cell genes (fusion-4 to fusion-6), as well as repression of terminal branching genes (DSRF and terminal-1) (42, 46) . Expression of two early-expressing fusion cell genes (fusion-2 and fusion-3) are not dependent on esg. dys expression is also dependent on esg, in keeping with the role of esg in regulating early-expressing fusion cell gene expression. As with other genes expressed in fusion cells, dys expression was not dependent on esg in dorsal trunk cells. This implies that the ability of esg to activate transcription is fusion cell dependent and is due to the presence of different coregulatory proteins or modifier proteins in the different branches.
Cross-regulatory interactions among bHLH-PAS proteins. The trh gene is required for initiation of tracheal formation. trh expression is maintained throughout embryonic development in most tracheal cells, and this continued expression is due to autoregulation (50) . However, the role of trh beyond its role in initiating tracheal formation is not well understood. We have shown that Trh protein levels fall specifically in all classes of tracheal fusion cells coincident with the rise in Dys levels. The nuclear levels of Tgo, the partner for both Dys and Trh, remain constant in fusion cells. The biological significance of the reduction in Trh remains to be investigated, but it is possible that fusion requires a reduction in Trh. One possibility is that Trh: Tgo is required for the expression or function of the breathless (btl) tyrosine kinase receptor that guides growing tracheal branches (31) and that btl function must be inhibited in fusion cells. Potentially, the only function of dys is to reduce Trh levels.
There are multiple mechanisms in which Dys could regulate Trh levels. These mechanisms include (i) competition between Dys and Trh for dimerization with Tgo, (ii) competitive Dys: Tgo binding to Trh:Tgo autoregulatory binding sites in the trh gene, (iii) activation of genes by Dys that encode proteins influencing trh RNA or protein stability, and (iv) inhibition of protein kinase B that is required for Trh nuclear transport (19) . Conceptually, the first model is the simplest and most attractive. Trh autoregulates its own expression (50) , and reduction in Trh:Tgo complexes by competition for Tgo by Dys would lead to a reduction in trh RNA and protein. In the second model, Dys:Tgo would function as a transcriptional repressor and extinguish trh RNA synthesis by binding Trh:Tgo autoregulatory sequences within the trh gene.
Evidence for the possible roles of these mechanisms has emerged from studies on vertebrate and Drosophila bHLH-PAS proteins. In one study (13) , it was demonstrated that HIF-1␣ outcompetes the Aryl hydrocarbon receptor (Ahr) bHLH-PAS protein for their common dimerization partner, Arnt, which is the vertebrate Tgo ortholog. In another study (52) , Sim2 was shown to compete with HIF-1␣ for Arnt and partially block expression of a HIF-1␣:Arnt responsive reporter gene. Sim2 can repress transcription and, by binding to HIF-1␣:Arnt recognition sites on the reporter gene, it reduced its expression. The third model in which the presence of Dys reduces protein levels by activating the transcription of repressive or inhibitory factors is analogous to how Sim:Tgo represses the expression of genes in the central nervous system midline cells by activating transcription of a repressor (10) . One additional issue is whether Dys reduces the levels of Drosophila bHLH-PAS proteins besides Trh. One possibility is Sim. Both Sim and Dys are expressed in anal pad cells (36) , and sim mutants have anal pad defects (26, 36) . Evolution of bHLH-PAS proteins. Drosophila has four bHLH-PAS proteins that dimerize with Tgo: Sim, Sima, Ss, and Trh. Dys is also likely to dimerize with Tgo. One particularly interesting observation is that Drosophila Dys, Trh, and Sima are all involved in aspects of tracheal development. Mammals have closely related members of all of these proteins (Fig. 2) . The mammalian proteins dimerize with either Arnt or the closely related Arnt2. C. elegans has four bHLH-PAS partners for AHA-1, the worm Tgo/Arnt ortholog. These partners include (i) C15C8.2, which is related to Dys and mammalian NXF; (ii) AHR-1, which is related to Drosophila Ss and vertebrate Ahr; (iii) HIF-1, which is related to Drosophila Sima and vertebrate HIF-1␣; and (iv) T01D3.2, which is related to Sim and Trh. Since orthologs of Dys, Ss, Sima, and Sim/Trh are found in vertebrates, insects, and nematodes, these proteins had already diverged in the common ancestor of these species. The C. elegans C15C8.2 gene is expressed in the pharynx, a feeding organ (Powell-Coffman, unpublished). The mammalian dys gene, NXF, has been detected only in the brain (Patterson, unpublished). The evolutionary conservation of the Dys subfamily of proteins suggests a functional relationship, although the sites of expression in Drosophila and the other organisms, as studied to date, are diverse. One possibility based on the tracheal fusion phenotypes is that Dys regulates aspects of cell recognition or cell adhesion events. It will be interesting to determine in future studies what biochemical, developmental, or physiological features of the Dys proteins are conserved, as well as the evolutionary origins regarding the tracheal functions of Dys, Sima, and Trh.
